Adaptive Biotechnologies Corp (ADPT)
3.60
-0.12
(-3.23%)
USD |
NASDAQ |
May 17, 16:00
3.60
0.00 (0.00%)
After-Hours: 19:27
Adaptive Biotechnologies 1 Year Total Returns (Daily): -40.00% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | -40.00% |
May 15, 2024 | -39.91% |
May 14, 2024 | -38.70% |
May 13, 2024 | -41.18% |
May 10, 2024 | -50.84% |
May 09, 2024 | -49.22% |
May 08, 2024 | -51.82% |
May 07, 2024 | -51.02% |
May 06, 2024 | -49.29% |
May 03, 2024 | -59.87% |
May 02, 2024 | -58.20% |
May 01, 2024 | -62.04% |
April 30, 2024 | -63.31% |
April 29, 2024 | -61.48% |
April 26, 2024 | -64.51% |
April 25, 2024 | -64.92% |
April 24, 2024 | -68.48% |
April 23, 2024 | -69.97% |
April 22, 2024 | -70.78% |
April 19, 2024 | -71.73% |
April 18, 2024 | -71.87% |
April 17, 2024 | -70.32% |
April 16, 2024 | -65.23% |
April 15, 2024 | -63.21% |
April 12, 2024 | -63.09% |
Date | Value |
---|---|
April 11, 2024 | -67.93% |
April 10, 2024 | -68.92% |
April 09, 2024 | -65.97% |
April 08, 2024 | -67.13% |
April 05, 2024 | -69.40% |
April 04, 2024 | -68.73% |
April 03, 2024 | -69.23% |
April 02, 2024 | -66.25% |
April 01, 2024 | -64.78% |
March 28, 2024 | -61.04% |
March 27, 2024 | -66.86% |
March 26, 2024 | -65.84% |
March 25, 2024 | -62.99% |
March 22, 2024 | -59.14% |
March 21, 2024 | -60.12% |
March 20, 2024 | -57.91% |
March 19, 2024 | -59.18% |
March 18, 2024 | -60.30% |
March 15, 2024 | -60.58% |
March 14, 2024 | -59.95% |
March 13, 2024 | -58.92% |
March 12, 2024 | -55.12% |
March 11, 2024 | -52.75% |
March 08, 2024 | -58.94% |
March 07, 2024 | -59.88% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-83.55%
Minimum
Jun 14 2022
161.0%
Maximum
Mar 16 2021
-23.82%
Average
-36.23%
Median
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -83.33% |
Palatin Technologies Inc | -20.93% |
iBio Inc | -90.27% |
Theriva Biologics Inc | -48.06% |
Oragenics Inc | -43.06% |